GlassScriptPhysician profile
Morgan Rochelle Roberts
NPI 1730692039
$1,163.41
in general payments reported to CMS, 2019-2025
16 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $453 · 2022: $58.51 · 2023: $76.93 · 2024: $202 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $651.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $651.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $442.37 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $120.83 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $103.97 | 2021 | |
| Medtronic, INC. | $91.84 | 2021-2024 | Accurian, Synchromedii, Intellis Adaptivestim |
| Piramal Critical Care | $91.37 | 2023-2025 | |
| Supernus Pharmaceuticals, INC. | $49.29 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $47.38 | 2021 | |
| Allergan, INC. | $45.15 | 2021-2022 | |
| Acadia Pharmaceuticals INC | $43.00 | 2025 | Daybue |
| Amgen INC. | $30.84 | 2021-2022 | |
| Xeris Pharmaceuticals, INC. | $25.25 | 2021 | |
| Mdd US Operations, LLC | $24.08 | 2022 | |
| Kyowa Kirin, INC. | $14.03 | 2023 | Crysvita |
| Pfizer INC. | $13.64 | 2021 | |
| Lilly USA, LLC | $11.39 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $8.98 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Roberts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.